Morgan Stanley Coh Bar, Inc. Transaction History

Morgan Stanley

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 27, 2022	SELL	$0.17 - $0.34 $216 - $432	-1,273 Reduced 3.22%	38,277 $7,000
Q2 2022 Aug 15, 2022	SELL	$0.17 - $0.34 $216 - $432	-1,273 Reduced 3.22%	38,277 $7,000
Q1 2022 Oct 27, 2022	BUY	$0.25 - $0.43 $318 - $547	1,273 Added 3.33%	39,550 $12,000
Q1 2022 May 13, 2022	SELL	$0.25 - $0.43 $1,598 - $2,748	-6,392 Reduced 13.91%	39,550 $12,000
Q4 2021 Feb 14, 2022	BUY	$0.34 - $1.0 $14,813 - $43,570	43,570 Added 1836.85%	45,942 $16,000
Q3 2021 Nov 15, 2021	BUY	$0.96 - $1.62 $2,277 - $3,842	2,372 New	2,372 $2,000

1.14K

Ticker CWBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,906,940
Market Cap $1.57M
Description
CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.